Skip to main content
Veterinary Medicines

OCNIL 400 mg/g powder for use in drinking water

Authorised
  • Lincomycin hydrochloride

Product identification

Medicine name:
OCNIL 400 mg/g powder for use in drinking water
DOPHALIN 400 mg/g milteliai naudoti su geriamuoju vandeniu
Active substance:
  • Lincomycin hydrochloride
Target species:
  • Chicken
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    450.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        5
        day
      • Eggs
        no withdrawal period
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • bag of 150 g
  • bag of 1 Kg

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetpharma Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Mevet S.A.U.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/17/2402/001-002
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0242/001
Concerned member states:
  • Austria
  • Cyprus
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download

Labelling

English (PDF)
Published on: 22/12/2023
Download

RV2402.pdf

Lithuanian (PDF)
Published on: 1/10/2024
Download

eu-PUAR-esv0242001-dcp-ocnil-(dophalin)-400-mg-ml-poeder-for-use-in-drinking-water-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."